AMSBIO has announced a range of genomic DNA and cDNA products for immediate identification of genes.
The purified samples are designed to save valuable research time by allowing the immediate identification of genes of interest without the need to acquire tissues and perform in-house processing.
AMSBIO has added cancer and normal tissue cDNA arrays to its cDNA range, which also includes individual PCR-ready first strand samples and panels.
The cDNA in each array is synthesised from high quality total RNA from pathologically-verified tissues. Each array is provided with clinical information and QC data that has been both normalised and validated with ß-actin in two sequential qPCR analyses.
To aid the development of diagnostic tests and Next Generation Sequencing technology AMSBIO has also introduced genomic DNA isolated from FFPE tissue and 96-well genomic DNA plates for high-throughput gene profiling studies in automated gene analysis systems.